tratamiento quemado

Gus, E; Shahrokhi, S; Jeschke, M.
Burns, 2020-02-01, Volumen 46, Número 1, Páginas 19-32

portada - Burns - Vol. 40; No 6 (2014)Major thermal injury induces profound metabolic derangements secondary to an inflammatory “stress-induced” hormonal environment. Several pharmacological interventions have been tested in an effort to halt the hypermetabolic response to severe burns. Insulin, insulin growth factor 1, insulin growth factor binding protein 3, metformin, human growth hormone, thyroid hormones, testosterone, oxandrolone, and propranolol, among others, have been proposed to have anabolic or anticatabolic effects.

 

Grishkevich, V. M; Grishkevich, M; Menzul, V.
Burns Open, July 2018, Volume 2, Issue 3, Pages 130-138

Burns OpenBurns of anterior shoulder joint surface and neighboring areas produce shoulder edge adduction contracture and scar deformity, slowing down the development of upper limbs in pediatric patients. Therefore, surgical reconstruction is indicated as early as the contracture is formed. Currently used surgical techniques, based on counter transposition of the local triangular flaps and skin transplants, do not solve the problem because of incomplete release of the contractures. Repeated operations are often performed. The scar deformity also remains.

Nherera, L. M; Trueman, P; Roberts, C. D; Berg, L.
Burns, 2017-08-01, Volúmen 43, Número 5, Páginas 939-948

portada - Burns - Vol. 40; No 6 (2014)The purpose of this systematic review and meta-analysis was to assess the clinical effectiveness of nanocrystalline silver compared to alternative silver delivery systems (silver sulphadiazine [SSD] and silver nitrate) in adults and children with superficial and deep partial thickness burns.
PubMed, EMBASE, Cochrane and other databases were searched to identify relevant randomised controlled trials and observational studies.

 

Heyneman, A. et als.
Burns, 2016-11-01, Volúmen 42, Número 7, Pages 1377-1386

portada - Burns - Vol. 40; No 6 (2014)For more than 40 years, silver sulphadiazine 1% (SSD) is considered as standard therapy for the conservative treatment of burn wounds. However, in the last 10 years, substantial disadvantages of SSD have been reported in the literature and probably as a result of this, several new dressings for burn wounds have been developed and put on the market. The objective of this systematic review is to evaluate the available evidence on SSD in the conservative treatment of burns, specifically in comparison with the newer burn dressings that are increasingly being used nowadays.